IP Library Granted Patent US 8,784,380
Granted Patent B2
US 8,784,380 · App. 12/630,996 · Granted Jul 22, 2014

Method and device for painless injection of medication

Inventor: Eric James Wall (Cincinnati, OH)
Assignee: Children's Hospital Medical Center
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,784,380
App. No.
12/630,996
Granted
Jul 22, 2014
Kind
B2
Abstract

A method for providing a substantially painless injection of medication into a patient, including inserting an injection needle having an outside diameter greater than 0.20 mm and less than about 0.38 mm, and injecting a medicament through the needle and into the patient at a substantially constant volumetric flow rate of about 0.05 μL/s to about 50 μL/s that provides a painless injection. The method does not require the use of an anesthetic or that the medical personnel to spend a substantial amount of time performing the injection procedure, is relatively simple and inexpensive to perform and operate, and provides a relatively high degree of safety for both the medical personnel and for the patient.

Claims (20)

1. A self-contained device for injecting a medicament, comprising:

a) a housing that includes a base,

b) an injection needle disposed within the housing and having an injection end configured for insertion into the skin of a patient,

c) a reservoir containing a liquid medicament and configured for liquid communication with the injection needle,

d) a means for injecting the medicament from the reservoir to the injection end of the needle at a substantially constant volumetric flow rate of about 0.05 μL/s to about 50 μL/s, and

e) a bandage comprising a base-contacting surface releasably affixed to the base of the housing for semi-permanent attachment of the bandage to the base of the device, and a skin-contacting surface that comprises an affixment for temporary securement of the bandage to the skin.

2. The device according to claim 1 wherein the affixment of the bandage to the skin is greater than the affixment of the bandage to the base, whereby when the attached device is removed from the skin, the bandage detaches from the base of the device and remains attached to the skin.

3. The device according to claim 2 wherein the bandage comprises a pad portion through which the injection needle penetrates when moving between its first and second positions.

4. The device according to claim 3 wherein the pad portion is selected from the group consisting of a gauze, a wound dressing, and an absorbent material.

5. The device according to claim 4 wherein the affixment of the bandage to the skin comprises an attachment portion that includes a second adhesive, wherein the attachment portion surrounds the pad.

6. The device according to claim 2 wherein the affixment of the bandage to the base of the device comprises a first adhesive on the base of the device, and the affixment of the bandage to the skin comprises a second adhesive of the skin-contacting surface of the bandage.

7. The device according to claim 2 wherein the second affixment attaches the device to the skin without requiring medical personnel to hold the device.

8. The device according to claim 2 wherein the affixment of the bandage to the base comprises a first adhesive on the base of the device having an adhesion to the base that is greater than its adhesion to the attachment portion of the device-contacting side of the bandage.

9. The device according to claim 1 further comprising a means for inserting an injection end of the injection needle between a first position wherein injection end is within the housing and a second position wherein the injection end extends outwardly from the base and is inserted into the skin of the patient.

10. The device according to claim 9 further comprising a means for preselecting the depth of extension of the injection end of the needle at its second position.

11. The device according to claim 9 further comprising a means for retracting the injection end of the injection needle from the second position and a third position within the housing.

12. The device according to claim 1 wherein the substantially constant volumetric flow rate is about 0.5 μL/s to about 20 μL/s.

13. The device according to claim 12 wherein the substantially constant volumetric flow rate is about 1 μL/s to about 4 μL/s.

14. The device according to claim 1 wherein the needle has an outside diameter greater than 0.20 mm and less than about 0.38 mm.

15. The device according to claim 14 wherein the needle is selected from the group consisting of a 28 gauge needle, a 30 gauge needle, and a 32 gauge needle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2010
From: WALL, ERIC JAMES
To: CHILDREN'S HOSPITAL MEDICAL CENTER
Reel/Frame 024093/0112 →
Continuity (3)
Division 10605187 · Sep 12, 2003
Provisional Application 60410130 · Sep 12, 2002
Related Publication 20100076400A1 · Mar 25, 2010